4.7 Article

Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

PROTAC targeted protein degraders: the past is prologue

Miklos Bekes et al.

Summary: Targeted protein degradation (TPD) is a new therapeutic modality that can tackle disease-causing proteins which are difficult to target with conventional small molecules. PROTAC molecules, utilizing the ubiquitin-proteasome system to degrade target proteins, has achieved clinical proof-of-concept and attracted significant industry activity. Future directions include identifying target classes suitable for TPD, expanding the use of ubiquitin ligases for precision medicine, and extending the modality beyond oncology.

NATURE REVIEWS DRUG DISCOVERY (2022)

Review Oncology

Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming

Funmilayo O. Adeshakin et al.

Summary: Cancer cells develop mechanisms to resist anoikis, promoting invasion and metastasis. Understanding the mechanisms driving anoikis resistance is crucial for preventing tumor progression and metastasis, with metabolic pathways playing a key role in helping cells evade anoikis.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

MUC1: Structure, Function, and Clinic Application in Epithelial Cancers

Wenqing Chen et al.

Summary: MUC1 plays different roles in normal and cancer cells, acting as a protective factor in normal cells but potentially promoting malignancy and metastasis in cancer cells. Its involvement in cancer therapy is promising and currently being researched for clinical applications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, General & Internal

Assessment of Image-Guided Intratumoral Delivery of Immunotherapeutics in Patients With Cancer

Rahul A. Sheth et al.

JAMA NETWORK OPEN (2020)

Review Immunology

Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer

Jos P. M. van Putten et al.

JOURNAL OF INNATE IMMUNITY (2017)

Review Endocrinology & Metabolism

Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells

Inge M. N. Wortel et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)

Editorial Material Cell Biology

Cancer cell resistance to anoikis: MUC1 glycosylation comes to play

Lu-Gang Yu

CELL DEATH & DISEASE (2017)

Article Cell Biology

MUC1 O-glycosylation contributes to anoikis resistance in epithelial cancer cells

Tushar Piyush et al.

CELL DEATH DISCOVERY (2017)

Article Hematology

MUC1-C drives MYC in multiple myeloma

Ashujit Tagde et al.

Article Oncology

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors

Laura Jeffords Moore et al.

TRANSLATIONAL ONCOLOGY (2016)

Article Oncology

MUC1 stimulates EGFR expression and function in endometrial cancer

Brian J. Engel et al.

ONCOTARGET (2016)

Article Pharmacology & Pharmacy

Pancreatic Cancer Metastasis: Are we being Pre-EMTed?

Srustidhar Das et al.

CURRENT PHARMACEUTICAL DESIGN (2015)

Review Biochemistry & Molecular Biology

Cell Regulation by Phosphotyrosine-Targeted Ubiquitin Ligases

Jonathan A. Cooper et al.

MOLECULAR AND CELLULAR BIOLOGY (2015)

Review Pharmacology & Pharmacy

Cancer metastases: challenges and opportunities

Xiangming Guan

ACTA PHARMACEUTICA SINICA B (2015)

Review Biochemistry & Molecular Biology

MUC1: a multifaceted oncoprotein with a key role in cancer progression

Sritama Nath et al.

TRENDS IN MOLECULAR MEDICINE (2014)

Article Oncology

Altered Mucins (MUC) Trafficking in Benign and Malignant Conditions

Suhasini Joshi et al.

ONCOTARGET (2014)

Review Biochemistry & Molecular Biology

Anoikis molecular pathways and its role in cancer progression

Paolo Paoli et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)

Article Biochemistry & Molecular Biology

Activated EGFR Stimulates MUC1 Expression in Human Uterine and Pancreatic Cancer Cell Lines

Neeraja Dharmaraj et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2013)

Review Oncology

Anoikis: an emerging hallmark in health and diseases

M. L. Taddei et al.

JOURNAL OF PATHOLOGY (2012)

Article Biochemistry & Molecular Biology

Anti-MUC1 antibody inhibits EGF receptor signaling in cancer cells

Akinori Hisatsune et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Cell Biology

Overcoming anoikis - pathways to anchorage-independent growth in cancer

Marta C. Guadamillas et al.

JOURNAL OF CELL SCIENCE (2011)

Article Biochemistry & Molecular Biology

MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop

Rehan Ahmad et al.

SCIENCE SIGNALING (2011)

Review Oncology

Mucins in cancer: function, prognosis and therapy

Donald W. Kufe

NATURE REVIEWS CANCER (2009)

Article Pathology

CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma

Takamasa Uekita et al.

AMERICAN JOURNAL OF PATHOLOGY (2008)

Review Oncology

Anoikis resistance and tumor metastasis

Craig D. Simpson et al.

CANCER LETTERS (2008)

Article Biochemistry & Molecular Biology

The Cytoplasmic Tail of MUC1: A Very Busy Place

Daniel D. Carson

SCIENCE SIGNALING (2008)

Article Oncology

MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1

JJ Rahn et al.

CLINICAL & EXPERIMENTAL METASTASIS (2005)

Article Biochemistry & Molecular Biology

MUC1 membrane trafficking is modulated by multiple interactions

CL Kinlough et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Ubiquitin-dependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells

C Marques et al.

FASEB JOURNAL (2004)

Article Oncology

Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer

P Mukherjee et al.

JOURNAL OF IMMUNOTHERAPY (2003)

Article Biochemistry & Molecular Biology

ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene

F Siu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Article Cell Biology

The conserved Pkh-Ypk kinase cascade is required for endocytosis in yeast

AKA deHart et al.

JOURNAL OF CELL BIOLOGY (2002)

Review Oncology

MUC1, the renaissance molecule

SJ Gendler

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2001)